Validation, Orientation, & the New Classification of Rosacea
At a Glance
Doctors now diagnose rosacea using a modern phenotype-based approach, which focuses on your specific observable symptoms rather than rigid subtypes. The presence of either persistent central facial redness or thickened, bumpy skin is enough to confirm a diagnosis. The significant emotional and psychological impact of rosacea is also medically recognized.
Finding out you have rosacea can feel overwhelming, especially if you have been scouring the internet and seeing dramatic images or confusing terminology. It is important to take a breath and realize that rosacea is a common, manageable chronic inflammatory dermatosis (a long-term skin condition involving inflammation) that primarily affects the face [1]. While it can be frustrating, understanding the current medical consensus on how it is identified and classified can help you move from a place of panic to a place of proactive management.
A Modern Way of Looking at Rosacea
For years, doctors classified rosacea into four rigid “subtypes” (such as “acne rosacea” or “ocular rosacea”). However, in 2017 and 2019, major global organizations, including the National Rosacea Society (NRS) and the ROSCO (Rosacea Consensus) panel, officially shifted to a phenotype-based approach [2][3].
A phenotype is simply an observable characteristic or symptom. This shift was made because rosacea symptoms often overlap, change, or appear together in ways that the old “subtype” boxes couldn’t capture [3]. Instead of trying to fit you into one category, your doctor now looks at your specific “features” to tailor your treatment.
The Two Signs That Confirm a Diagnosis
Current clinical guidelines state that if you have either of the following two features, it is “independently diagnostic,” meaning your doctor can confirm you have rosacea without needing any other symptoms present [3]:
- Fixed Centrofacial Erythema: This is persistent redness on the central part of your face (the nose, cheeks, chin, and forehead) that does not go away [4][5]. It may get brighter at times, but the underlying redness is always there.
- Phymatous Changes: This refers to skin thickening and the development of an irregular, “bumpy” texture [4]. While this most commonly occurs on the nose (a condition called rhinophyma), it can occur elsewhere on the face.
Other features, such as “pimples” (papules and pustules), visible “spider veins” (telangiectasia), or eye irritation (ocular features), are also common but are considered “major” or “minor” signs rather than standalone diagnostic proof [3][6].
Validating the Emotional Toll
If you feel anxious, embarrassed, or even depressed because of your skin, please know that these feelings are scientifically recognized and valid. Rosacea is not “just a cosmetic issue.” Because it affects the face—the primary way we interact with the world—it carries a significant psychosocial burden [7].
- Anxiety and Depression: Research shows that people with rosacea are at a higher risk for developing depression and social anxiety [8][9]. The level of social anxiety can be similar to that experienced by people with severe acne [10].
- Sleep Disturbance: There is a documented link between rosacea and an increased risk of insomnia and other sleep disorders [11]. This may be due to the physical discomfort of the skin or the emotional stress of the condition.
- Self-Esteem: The visible nature of the condition can impact self-perception and quality of life [7].
The good news is that the medical community now emphasizes a “whole person” approach. Treating the visible skin symptoms has been shown to directly improve health-related quality of life and emotional well-being [12]. You are not alone, and your emotional health is just as important as your skin health.
Common questions in this guide
What is the new way doctors diagnose rosacea?
What are the main signs that confirm a rosacea diagnosis?
What is the difference between rosacea redness and regular flushing?
Is it normal to feel depressed or anxious about my rosacea?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the phenotype-based approach, which specific features (erythema, papules, phymatous changes) are you currently seeing in my skin?
- 2.Do I have either of the two 'independently diagnostic' features that confirm a rosacea diagnosis?
- 3.Is the redness I'm seeing 'fixed centrofacial erythema,' and how does that differ from temporary flushing?
- 4.How do you recommend we monitor for potential skin thickening or phymatous changes over time?
- 5.Can you recommend resources or specialists to help me manage the social anxiety and sleep issues I've been experiencing since my symptoms started?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.
van Zuuren EJ, Fedorowicz Z, Tan J, et al.
The British journal of dermatology 2019; (181(1)):65-79 doi:10.1111/bjd.17590.
PMID: 30585305 - 2
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel.
Schaller M, Almeida LMC, Bewley A, et al.
The British journal of dermatology 2020; (182(5)):1269-1276 doi:10.1111/bjd.18420.
PMID: 31392722 - 3
Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel.
Tan J, Almeida LM, Bewley A, et al.
The British journal of dermatology 2017; (176(2)):431-438 doi:10.1111/bjd.15122.
PMID: 27718519 - 4
Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.
Guertler A, Jøntvedt NM, Clanner-Engelshofen BM, et al.
Journal of cosmetic dermatology 2020; (19(10)):2627-2633 doi:10.1111/jocd.13591.
PMID: 32623833 - 5
A randomized, controlled, split-face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea.
Wei D, Hamblin MR, Wen X
Journal of cosmetic dermatology 2021; (20(12)):3968-3973 doi:10.1111/jocd.14347.
PMID: 34333845 - 6
Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis.
Jørgensen AR, Egeberg A, Gideonsson R, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(12)):2010-2015 doi:10.1111/jdv.14352.
PMID: 28543746 - 7
Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.
Zeichner JA, Eichenfield LF, Feldman SR, et al.
The Journal of clinical and aesthetic dermatology 2018; (11(2)):47-52.
PMID: 29552276 - 8
Patients with Rosacea Have Increased Risk of Depression and Anxiety Disorders: A Danish Nationwide Cohort Study.
Egeberg A, Hansen PR, Gislason GH, Thyssen JP
Dermatology (Basel, Switzerland) 2016; (232(2)):208-13 doi:10.1159/000444082.
PMID: 26954304 - 9
Association of rosacea with depression and anxiety: A systematic review and meta-analysis.
Chang HC, Huang YC, Lien YJ, Chang YS
Journal of affective disorders 2022; (299()):239-245 doi:10.1016/j.jad.2021.12.008.
PMID: 34879261 - 10
The Psychosocial Impact of Chronic Facial Dermatoses in Adults.
Ozcan Y, Sungur MA, Ozcan BY, et al.
Dermatology practical & conceptual 2023; (13(1)) doi:10.5826/dpc.1301a29.
PMID: 36892338 - 11
Increased risk of sleep disturbances in patients with rosacea: A nationwide population-based cohort study.
Chae K, Cho M, Kim S, Woo YR
The Journal of dermatology 2024; (51(1)):70-75 doi:10.1111/1346-8138.17012.
PMID: 37905567 - 12
Health-related Quality of Life of Patients with Rosacea: A Systematic Review and Meta-analysis of Real-world Data.
Chiu CW, Tsai J, Huang YC
Acta dermato-venereologica 2024; (104()):adv40053 doi:10.2340/actadv.v104.40053.
PMID: 38916178
This page explains rosacea classification and diagnostic criteria for educational purposes. It does not replace a professional evaluation by a dermatologist or healthcare provider.
Get notified when new evidence is published on rosacea.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.